Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-449-1 | CAS number: 818-08-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 November 2018 to 15 December 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Dibutyltin oxide
- EC Number:
- 212-449-1
- EC Name:
- Dibutyltin oxide
- Cas Number:
- 818-08-6
- Molecular formula:
- C8H18OSn
- IUPAC Name:
- dibutylstannanone
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Appearance: white powder
1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: In-house bred animals
- Females nulliparous and non-pregnant: Yes
- Age at study initiation: 9 weeks
- Weight at study initiation: 162.1 g to 177.89 g
- Fasting period before study: Three animals per step were fasted overnight (16 to 18 hours) prior to dosing. Water was provided ad libitum during the fasting period. Feed was offered 3 to 4 hours after dosing.
- Housing: Three animals were housed in standard polypropylene cage with stainless steel mesh top grill. Clean sterilised paddy husk was provided as bedding material.
- Diet: Ad libitum
- Water: Ad libitum
- Acclimation period: Healthy young animas used for Step-I, Step-I confirmation, Step-II and Step-II confirmation were acclimatised for five, eight, eleven and thirteen days respectively to laboratory conditions prior to treatment and were observed for clinical signs once daily. Veterinary examination of all animals was performed on the day of receipt and on the 5th day of acclimatisation.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.3 - 22.9 °C
- Humidity (%): 47 % - 67 % relative humidity
- Air changes (per hr): 12 to 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours fluorescent light and 12 hours dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 and 200 mg/mL
- Justification for choice of vehicle: The test material formed uniform suspension in corn oil as evidenced by in-house solubility/suspensibility test. Hence, corn oil was selected for the test material formulation preparation. Corn oil is a universally accepted and routinely used vehicle in oral toxicity studies.
- Lot/batch no.: A1712001
MAXIMUM DOSE VOLUME APPLIED
- The dose volume administered to individual rats was adjusted according to its bodyweight recorded on the day of dosing. The dose volume was 10 mL/kg body weight.
DOSAGE PREPARATION
- The required quantity of test material was weighed, ground well using a pestle and mortar by adding a little volume of vehicle and transferred to a measuring cylinder. A small quantity of vehicle was added, rinsed and transferred into the measuring cylinder. Rinsing procedure was repeated until the complete transfer of contents to the measuring cylinder. Finally the volume was made up to the required quantity with vehicle to get the desired concentration.
- The freshly prepared test material formulation was used for administration. The homogeneity of the test material formulation was maintained by continuous stirring on a magnetic stirrer during dosing.
METHOD
- The freshly prepared test formulation was administered by oral gavage to each rat as a single dose using intubation cannula.
- The animals were dosed in a stepwise procedure with three female animals per step. A starting dose of 300 mg/kg body weight was selected from the fixed dose levels of 5, 50, 300 and 2000 mg/kg body weight as the LD50 of the test material was not available.
- The test material was administered by oral gavage as a single dose of 300 mg/kg body weight to three female rats in step-I. Clinical signs of toxicity and no mortality was observed at 300 mg/kg body weight in Step-I. Hence, as per the decision rules governing the sequential procedure presented in the OECD 423 guideline, Step-I confirmation was conducted using three more female rats after approximately 48 hours observation by administering a single dose of 300 mg/kg body weight of the test material. Clinical signs of toxicity and no mortality was observed at 300 mg/kg body weight in Step-I confirmation. Step-II was conducted using three more female rats after approximately 48 hours of observation by administering a single dose of 2000 mg/kg body weight. Clinical signs of toxicity and mortality were observed at 2000 mg/kg body weight in Step-II. Step-II confirmation was conducted using three more female rats after approximately 24 hours of observation by administering a single dose at 2000 mg/kg body weight. Clinical signs of toxicity and mortality were observed at 2000 mg/kg body weight in Step-II confirmation.
- Dose levels higher than 2000 mg/kg body weight were not tested. - Doses:
- 300 and 2000 mg/kg body weight
- No. of animals per sex per dose:
- Three females per step
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All surviving animals were observed for clinical signs of toxicity and mortality at 30 to 40 min, 1 hour (± 10 mins), 2 hours (± 10 mins), 3 hours (± 10 mins), and 4 hours (± 10 mins) post-dosing on day 1 and once daily thereafter for clinical signs of toxicity and twice daily for mortality during the 14 day observation period. Individual animal body weight was recorded on day 2 before test material administration and on day 8 and day 15 during the observation period. The body weight of dead animals was also recorded.
- Necropsy of survivors performed: Yes. At the end of the observation period, all surviving animals were humanely sacrificed under carbon dioxide asphyxiation, subjected to necropsy and a complete gross pathological examination and observations were recorded. In dead animals external gross changes were observed, hence tissues (stomach) were collected and preserved in 10 % neutral buffered formalin. Histopathological examination was not carried out on the collected tissues as per the sponsor’s request.
- Other examinations performed: Observations included changes in skin, fur, eyes and mucous membranes and also respiratory, circulatory, autonomic and central nervous system and somatomotor activity and behaviour pattern.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 500 mg/kg bw
- Based on:
- test mat.
- Mortality:
- - In Step-I and Step-I confirmation, no mortality was observed.
- In Step-II on day 4 one animal was found dead; one animal revealed clinical signs and was found dead by afternoon observation. The surviving animal was found dead on day 6 observation.
- In Step-II confirmation all animals were found dead on Day 5 observation. - Clinical signs:
- other: - In Step-I and Step-I confirmation, the animals were dosed at 300 mg/kg body weight. No clinical signs of toxicity and mortality were observed at 30 to 40 minutes; diarrhoea was observed at 1st, 2nd, 3rd and 4th hour observations. On day 2 clinical sig
- Gross pathology:
- - No gross pathological changes were observed in any of the surviving animals at 300 mg/kg body weight. However, in dead animals external gross change like wet perineum (6/6) and internal gross change like stomach haemorrhage (5/6) and autolysis (1/6) was observed.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Under the conditions of the study it was concluded that the LD50 cut off value for the test material was 500 mg/kg bodyweight.
- Executive summary:
The test material was evaluated for acute oral toxicity in Sprague Dawley rats according to the standardised method OECD Guideline 423, under GLP conditions.
A starting dose of 300 mg/kg body weight was selected from the fixed dose levels of 5, 50, 300 and 2000 mg/kg body weight as the LD50 of the test material was not available.
A total of 12 females (3 females for each Step-I, Step-I confirmation, Step-II and Step-II confirmation) were used for the experiment. All animals of Step-I and Step-I confirmation were administered 300 mg/kg body weight of the test material formulation and Step-II and Step-II confirmation were administered with 2000 mg/kg body weight of the test material formulation through the oral route.
All surviving animals were observed for clinical signs of toxicity and mortality at 30 to 40 min, 1 h (± 10 mins), 2 h (± 10 mins), 3 h (± 10 mins) and 4 hours (± 10 mins) post dosing on day 1 and once daily thereafter for clinical signs of toxicity and twice daily for mortality during the 14 day observation period. Body weight was recorded on day 1 before test material administration and on day 8 and day 15 during the observation period. At the end of the observation period, all surviving animals were sacrificed under carbon dioxide asphyxiation, subjected to necropsy and gross pathological examination.
In Step-I and Step-I confirmation the animals were dosed with 300 mg/kg body weight. Animals revealed clinical signs like diarrhoea and wet perineum. Clinical signs reversed back to normal by day 4 observation.
In Step-II and Step-II confirmation, the animals were dosed with 2000 mg/kg body weight. Animals revealed clinical signs like lethargy, diarrhoea, wet perineum and nasal discharge followed by death.
No changes were observed in body weight and percent change in body weight with respect to day 1 at 300 mg/kg body weight. All surviving animals revealed physiologically normal increase in the body weight.
No gross pathological changes were observed in any of the surviving animals at 300 mg/kg body weight. However, in dead animals external gross change like wet perineum (6/6) and internal gross change like stomach haemorrhage (5/6) and autolysis (1/6) was observed.
Under the conditions of the study it was concluded that the LD50 cut off value for the test material was 500 mg/kg bodyweight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.